Literature DB >> 12163337

Gold opens mitochondrial pathways to apoptosis.

Mark J McKeage1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12163337      PMCID： PMC1573450          DOI： 10.1038/sj.bjp.0704822

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  9 in total

Review 1.  Mitochondria as the central control point of apoptosis.

Authors:  S Desagher; J C Martinou
Journal:  Trends Cell Biol       Date:  2000-09       Impact factor: 20.808

Review 2.  Mitochondrion as a novel target of anticancer chemotherapy.

Authors:  P Costantini; E Jacotot; D Decaudin; G Kroemer
Journal:  J Natl Cancer Inst       Date:  2000-07-05       Impact factor: 13.506

Review 3.  Mitochondria as target for antiischemic drugs.

Authors:  D Morin; T Hauet; M Spedding; J Tillement
Journal:  Adv Drug Deliv Rev       Date:  2001-07-02       Impact factor: 15.470

Review 4.  Mitochondria: execution central.

Authors:  R A Gottlieb
Journal:  FEBS Lett       Date:  2000-09-29       Impact factor: 4.124

5.  Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma.

Authors:  J S Waters; A Webb; D Cunningham; P A Clarke; F Raynaud; F di Stefano; F E Cotter
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

6.  Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability.

Authors:  M P Rigobello; M T Callegaro; E Barzon; M Benetti; A Bindoli
Journal:  Free Radic Biol Med       Date:  1998-01-15       Impact factor: 7.376

7.  Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative.

Authors:  Maria Pia Rigobello; Guido Scutari; Rita Boscolo; Alberto Bindoli
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

8.  Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds.

Authors:  S Gromer; L D Arscott; C H Williams; R H Schirmer; K Becker
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

9.  Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.

Authors:  C K Mirabelli; R K Johnson; C M Sung; L Faucette; K Muirhead; S T Crooke
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701
  9 in total
  3 in total

1.  The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells.

Authors:  Seon-Joo Park; In-Sook Kim
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

2.  Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro.

Authors:  I S Kim; J Y Jin; I H Lee; S J Park
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

Review 3.  The medicinal applications of imidazolium carbene-metal complexes.

Authors:  Khadijah M Hindi; Matthew J Panzner; Claire A Tessier; Carolyn L Cannon; Wiley J Youngs
Journal:  Chem Rev       Date:  2009-08       Impact factor: 60.622
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.